Search results
Results From The WOW.Com Content Network
Intravitreal injection is the method of administration of drugs into the eye by injection with a fine needle. The medication will be directly applied into the vitreous humor. [1] It is used to treat various eye diseases, such as age-related macular degeneration (AMD), diabetic retinopathy, and infections inside the eye such as endophthalmitis. [1]
Oxymetazoline, sold under the brand name Afrin among others, is a topical decongestant and vasoconstrictor medication. It is available over-the-counter as a nasal spray to treat nasal congestion and nosebleeds, as eye drops to treat eye redness due to minor irritation, and (in the United States) as a prescription topical cream to treat persistent facial redness due to rosacea in adults.
Treatment of AMD varies depending on the category of the disease at the time of diagnosis. In general, treatment is aimed at slowing down the progression of AMD. [69] As of 2018, there are no treatments to reverse the effects of AMD. [69] As of 2024, there are two drugs to dissolve the drusen in dry AMD, see below.
Micrograph of heart muscle showing lipofuscin pigment, H&E stain. Lipofuscin accumulation in the eye, is a major risk factor implicated in macular degeneration, a degenerative disease, [15] and Stargardt disease, an inherited juvenile form of macular degeneration.
Macular hard drusen in the right eye. 65-year-old diabetic woman. Drusen, from the German word for node or geode (singular, "Druse"), are tiny yellow or white accumulations of extracellular material that build up between Bruch's membrane and the retinal pigment epithelium of the eye. The presence of a few small ("hard") drusen is normal with ...
Cost: $7 | Active ingredients: Lidocaine | Type: Cream | Amount: 4.3 ounces. Lidocaine is another popular ingredient found in pain relief creams. It's a topical anesthetic that's often used to ...
The management of strabismus may include the use of drugs or surgery to correct the strabismus.Agents used include paralytic agents such as botox used on extraocular muscles, [1] topical autonomic nervous system agents to alter the refractive index in the eyes, and agents that act in the central nervous system to correct amblyopia.
Researchers have recently developed a new drug that will ultimately shrink down and dissolve cataracts -- the leading cause of human blindness that affects tens of millions of people worldwide. ...